Published: 18 May 2019
Author(s): Marco Di Carlo, Fausto Salaffi, Elisa Gremese, Florenzo Iannone, Giovanni Lapadula, Gianfranco Ferraccioli, on behalf of the GISEA Study Group
Issue: May 2019
Section: Original Article

Body mass index (BMI) demonstrated to influence the clinical response to different drugs in rheumatoid arthritis (RA). The aim of this study was to investigate the role of BMI in the achievement of remission in active RA patients starting the treatment with abatacept.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.